The Truth Behind Cambrian's (寒武纪) RMB 6.5 Billion Profit: 20% Foundry Yield Ceiling and ByteDance's (字节跳动) 'Hidden Weapon'

The headline number — and the puzzle behind it

Cambrian (寒武纪) reported a striking net profit of about RMB 6.5 billion, a headline figure that has drawn intense market attention. But it has been reported that internal manufacturing yields on some of its key AI chips are stuck at roughly 20% — meaning only one in five wafers (or chips) reaches usable specification. How do you square blockbuster profits with industrial-scale wastage? The gap has prompted analysts and investors to ask whether accounting, pricing, subsidized manufacturing, or undisclosed customer relationships are masking the true economics.

Foundry yields, node constraints and cost math

Chip yields matter because poor yields drive per-unit costs sharply higher. In China’s domestic chip ecosystem — constrained by U.S. export controls on advanced manufacturing equipment — many design houses rely on older nodes and nascent foundry processes that can produce uneven yields. A 20% ceiling would normally make commodity economics brutal unless mitigated by very high average selling prices, cross-subsidies, or internal consumption. It has been reported that some of Cambrian’s cost dynamics are atypical; observers suggest explanations ranging from premium pricing for differentiated AI inference chips to favorable accounting treatments or one-off items on the profit statement.

ByteDance’s reported role and geopolitical implications

Reportedly, ByteDance (字节跳动) has been quietly using domestic AI accelerators — described by some as a “hidden weapon” — to power large-scale inference for its recommendation engines and content platforms. If true, heavy internal absorption of imperfect-but-usable chips by a single large customer could smooth manufacturing pain and support high reported margins. There’s a geopolitical angle too: Chinese internet giants buying domestic chips reduces reliance on Western suppliers amid tightening tech controls, but it also raises questions about commercial transparency and investor risk. For now, the claims remain partly unverified and call for clearer disclosure from Cambrian and its partners.